PDF herunterladen
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2018; 22(03): 317-329
DOI: 10.1055/s-0037-1604055
Systematic Review
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

A Review of Traditional Vaccine-Preventable Diseases and the Potential Impact on the Otolaryngologist

Christopher J. Greenlee
1   Department of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, United States
2   Department of Otolaryngology, Children's Hospital Colorado, Aurora, Colorado, United States
,
Stephen S. Newton
1   Department of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, United States
2   Department of Otolaryngology, Children's Hospital Colorado, Aurora, Colorado, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

12. September 2016

07. Mai 2017

Publikationsdatum:
25. Juli 2017 (online)

   Lizenzen und Reprints

Abstract

Introduction A majority of otolaryngologists have not had direct experience with many vaccine-preventable diseases since the creation of national vaccination programs. Despite the elimination of endemic transmission of some of these diseases in the United States, outbreaks can occur anywhere and still pose a threat to public health around the world. Recent outbreaks and changing trends in exemption rates indicate that it is important for physicians to maintain a working knowledge of how these diseases present and of the recommended treatment guidelines.

Objectives This review will evaluate the current state of vaccination rates, vaccine exemption rates and disease incidence in the United States and in the world. It will also examine the clinical presentation and treatment recommendations of these diseases.

Data Synthesis United States estimated vaccination rates, vaccine exemption rates and vaccine-preventable disease incidences were obtained from data compiled by the Centers for Disease Control and Prevention. World vaccination rates and disease incidences were obtained from the World Health Organization databases, which compile official figures reported by member states. A PubMed literature review provided information on the current state of vaccination exemptions and outbreaks in the United States.

Conclusion Vaccination and vaccine exemption rates continue to put the United States and many areas of the world at risk for outbreaks of vaccine-preventable diseases. Clinical guidelines should be reviewed in the event of a local outbreak.

Keywords

vaccine - otolaryngology - public health - disease outbreaks - disease eradication - vaccination
 

  • References

  • 1 Roush SW, Murphy TV. ; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298 (18) 2155-2163
    CrossrefPubMedGoogle Scholar
  • 2 Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15 (02) 265-302
    CrossrefPubMedGoogle Scholar
  • 3 Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis 2011; 52 (07) 911-916
    CrossrefPubMedGoogle Scholar
  • 4 Centers for Disease Control and Prevention (CDC). Absence of transmission of the d9 measles virus--Region of the Americas, November 2002-March 2003. MMWR Morb Mortal Wkly Rep 2003; 52 (11) 228-229
    PubMedGoogle Scholar
  • 5 Pan American Health Organization. Americas region is declared the world's first to eliminate rubella. Pan American Health Organization website. http://www.paho.org/hq/index.php?option=com_content&view=article&id=10798&Itemid=1926&lang=en . April 29, 2015. Accessed May 11, 2015
    Google Scholar
  • 6 Strebel PM, Papania MJ, Dayan GH, Haalsey NA. Measles vaccine. In: Plotkin S, Orenstein W, Offit P. , ed. Vaccines. 5th ed. Philadelphia, PA: Elsevier; 2008: 353-398
    Google Scholar
  • 7 Rubella. In: Atkinson W, Wolfe S, Hamborksy J, McIntyre L. , Eds. Epidemiology and prevention of vaccine-preventable diseases, Washington DC: Public Health Foundation; 2009: 157-176
    Google Scholar
  • 8 Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Notifiable Diseases and Mortality Tables February 19, 2016. Available at the Centers for Disease Control and Prevention Website. http://www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6506md.pdf . February 13, 2016. Accessed February 18, 2016
    Google Scholar
  • 9 Chen RT, Hibbs B. Vaccine safety: current and future challenges. Pediatr Ann 1998; 27 (07) 445-455
    CrossrefPubMedGoogle Scholar
  • 10 Omer SB, Richards JL, Ward M, Bednarczyk RA. Vaccination policies and rates of exemption from immunization, 2005-2011. N Engl J Med 2012; 367 (12) 1170-1171
    CrossrefPubMedGoogle Scholar
  • 11 World Health Organization. Baccille Calmette Guérin vaccine. WHO vaccine-preventable diseases: monitoring system 2015 global summary. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragebcg.html . Accessed March 10th , 2015
    Google Scholar
  • 12 World Health Organization. Diphtheria reported cases. WHO vaccine-preventable diseases: monitoring system 2015 global summary. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencediphtheria.html . Accessed March 10th 2015
    Google Scholar
  • 13 Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16-17 March 2000. J Infect Dis 2004; 189 (Suppl. 01) S43-S47
    CrossrefPubMedGoogle Scholar
  • 14 Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360 (19) 1981-1988
    CrossrefPubMedGoogle Scholar
  • 15 Blank NR, Caplan AL, Constable C. Exempting schoolchildren from immunizations: states with few barriers had highest rates of nonmedical exemptions. Health Aff (Millwood) 2013; 32 (07) 1282-1290
    CrossrefPubMedGoogle Scholar
  • 16 McNutt LA, Desemone C, DeNicola E. , et al. Affluence as a predictor of vaccine refusal and underimmunization in California private kindergartens. Vaccine 2016; 34 (14) 1733-1738
    CrossrefPubMedGoogle Scholar
  • 17 National Conference of State Legisliatures. States with religious and philosophical exemptions from school immunization requirements, 2016. Available at: http://www.ncsl.org/research/health/school-immunization-exemption-state-laws.aspx . Accessed March 17, 2017
    Google Scholar
  • 18 Wang E, Clymer J, Davis-Hayes C, Buttenheim A. Nonmedical exemptions from school immunization requirements: a systematic review. Am J Public Health 2014; 104 (11) e62-e84
    PubMedGoogle Scholar
  • 19 Centers for Disease Control and Prevention. Vaccination coverage among children in kindergarten- United States,2014–15 school year. MMWR Morb Mortal Wkly Rep 2015; 64 (33) 913-920
    CrossrefPubMedGoogle Scholar
  • 20 Richards JL, Wagenaar BH, Van Otterloo J. , et al. Nonmedical exemptions to immunization requirements in California: a 16-year longitudinal analysis of trends and associated community factors. Vaccine 2013; 31 (29) 3009-3013
    CrossrefPubMedGoogle Scholar
  • 21 Omer SB, Enger KS, Moulton LH, Halsey NA, Stokley S, Salmon DA. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis. Am J Epidemiol 2008; 168 (12) 1389-1396
    CrossrefPubMedGoogle Scholar
  • 22 Imdad A, Tserenpuntsag B, Blog DS, Halsey NA, Easton DE, Shaw J. Religious exemptions for immunization and risk of pertussis in New York State, 2000-2011. Pediatrics 2013; 132 (01) 37-43
    CrossrefPubMedGoogle Scholar
  • 23 Atwell JE, Van Otterloo J, Zipprich J. , et al. Nonmedical vaccine exemptions and pertussis in California, 2010. Pediatrics 2013; 132 (04) 624-630
    CrossrefPubMedGoogle Scholar
  • 24 Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000; 284 (24) 3145-3150
    CrossrefPubMedGoogle Scholar
  • 25 Wood D, Donald-Sherbourne C, Halfon N. , et al. Factors related to immunization status among inner-city Latino and African-American preschoolers. Pediatrics 1995; 96 (2 Pt 1): 295-301
    PubMedGoogle Scholar
  • 26 Luman ET, McCauley MM, Shefer A, Chu SY. Maternal characteristics associated with vaccination of young children. Pediatrics 2003; 111 (5 Pt 2, S1) 1215-1218
    PubMedGoogle Scholar
  • 27 Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live?. Pediatrics 2004; 114 (01) 187-195
    CrossrefPubMedGoogle Scholar
  • 28 Birnbaum MS, Jacobs ET, Ralston-King J, Ernst KC. Correlates of high vaccination exemption rates among kindergartens. Vaccine 2013; 31 (05) 750-756
    CrossrefPubMedGoogle Scholar
  • 29 Gust DA, Strine TW, Maurice E. , et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 2004; 114 (01) e16-e22
    CrossrefPubMedGoogle Scholar
  • 30 Bardenheier B, Yusuf H, Schwartz B, Gust D, Barker L, Rodewald L. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?. Arch Pediatr Adolesc Med 2004; 158 (06) 569-575
    CrossrefPubMedGoogle Scholar
  • 31 Plans-Rubió P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Hum Vaccin Immunother 2012; 8 (02) 184-188
    CrossrefPubMedGoogle Scholar
  • 32 Gastañaduy PA, Redd SB, Fiebelkorn AP. , et al; Division of Viral Disease, National Center for Immunization and Respiratory Diseases, CDC. Measles - United States, January 1-May 23, 2014. MMWR Morb Mortal Wkly Rep 2014; 63 (22) 496-499
    PubMedGoogle Scholar
  • 33 Papania MJ, Wallace GS, Rota PA. , et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr 2014; 168 (02) 148-155
    CrossrefPubMedGoogle Scholar
  • 34 World Health Organization. Country reported disease incidence time series. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencediphtheria.html . Accessed February 1st 2016
    Google Scholar
  • 35 Centers for Disease Control and Prevention. Chapter 3: Infectious diseases related to travel – Measles(Rubeola). In: Traveler's health: yellow book. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/measles.aspx . Accessed March 4th , 2015
    Google Scholar
  • 36 Centers for Disease Control and Prevention (CDC). Preventable measles among U.S. residents, 2001-2004. MMWR Morb Mortal Wkly Rep 2005; 54 (33) 817-820
    PubMedGoogle Scholar
  • 37 Kutty P, Rota J, Bellini W. , et al. Measles. In: Roush S. , ed. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2013. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html . Accessed March 10th 2015
    Google Scholar
  • 38 American Academy of Pediatrics. Measles. In: Pickering L. , ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 419-429
    Google Scholar
  • 39 Fiebelkorn AP, Barkskey A, Hickman C, Bellini W. Mumps. In: Roush S. , ed. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2012. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.html . Accessed March 10th 2015
    Google Scholar
  • 40 American Academy of Pediatrics. Mumps. In Pickering L. , ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 439-443
    Google Scholar
  • 41 McLean H, Redd S, Abernathy E, Icenogle J, Wallace G. Rubella. In: Roush S. , ed. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2012. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html . Accessed March 10th 2015
    Google Scholar
  • 42 American Academy of Pediatrics. Rubella. In: Pickering L. , ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 536-541
    Google Scholar
  • 43 Tejpratap SP, Tiwari MD. Diphtheria. In: Roush S. , ed. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt01-dip.html . Accessed March 10th 2015.
    Google Scholar
  • 44 American Academy of Pediatrics. Diphtheria. In: Pickering L. , ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 263-266
    Google Scholar
  • 45 Briere EC, Wang X. Haemophilus influenzae. In: Roush S. , ed. Manual for the surveillance of vaccine-preventable diseases. 6th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2015. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt02-hib.html . Accessed March 10th 2015
    Google Scholar
  • 46 American Academy of Pediatrics. Haemophilus influenzae. In: Pickering L. , ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003: 293-301
    Google Scholar
  • 47 Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. ; Centers for Disease Control and Prevention (CDC). Measles outbreak–California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep 2015; 64 (06) 153-154
    PubMedGoogle Scholar
  • 48 Tunkel DE, Cull WL, Jewett EAB, Brotherton SE, Britton CV, Mulvey HJ. Practice of pediatric otolaryngology: results of the future of pediatric education II project. Arch Otolaryngol Head Neck Surg 2002; 128 (07) 759-764
    CrossrefPubMedGoogle Scholar
  • 49 Jacobson Vann JC, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005; (03) CD003941
    PubMedGoogle Scholar
  • 50 Centers for Disease Control and Prevention. National Immunization Survey (NIS)- Children (19–35 months): US vaccination coverage reported via NIS, January-December 2014. http://www.cdc.gov/vaccines/imz-managers/coverage/nis/child/2014-released-child-teen.html . Accessed on February 1st 2016
    Google Scholar
  • 51 World Health Organization. Country Summaries of WHO/UNICEF estimated coverage. http://apps.who.int/immunization_monitoring/globalsummary/wucoveragecountrylist.html . Accessed February 1st 2016
    Google Scholar
  • 52 Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2009. MMWR Morb Mortal Wkly Rep 2011; 58 (53) 1-100 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5853a1.htm
    PubMedGoogle Scholar
  • 53 Center for Disease Control and Prevention. Summary of notifiable disease, United States 2008. MMWR Morb Mortal Wkly Rep 2010; 57 (54) 1-94
    Google Scholar
  • 54 Center for Disease Control and Prevention. Summary of notifiable disease, United States 2007. MMWR Morb Mortal Wkly Rep 2009; 56 (53) 1-94
    Google Scholar
  • 55 Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases--United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 55 (53) 1-92
    PubMedGoogle Scholar
  • 56 Center for Disease Control and Prevention. Summary of notifiable disease, United States 2005. MMWR Morb Mortal Wkly Rep 2007; 54 (53) 2-92
    Google Scholar
  • 57 Center for Disease Control and Prevention. Summary of notifiable disease, United States 2000. MMWR Morb Mortal Wkly Rep 2002; 49 (53) 1-102
    Google Scholar
  • 58 Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases, United States 1995. MMWR Morb Mortal Wkly Rep 1996; 44 (53) 1-87
    PubMedGoogle Scholar
  • 59 Anderson RM, Hollingsworth TD, Nokes DJ. Mathematical models of transmission and control. In. Detels R, Beaglehole R, Lansang MA, GUlliford M. , eds. Oxford Textbook of Public Health. New York: Oxford University Press; 2009. ; vol. 2:715–744
    Google Scholar
  • 60 Anderson RM. The concept of herd immunity and the design of community-based immunization programmes. Vaccine 1992; 10 (13) 928-935
    CrossrefPubMedGoogle Scholar